Simplex Trading’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,526
| Closed | -$5K | – | 10049 |
|
|
2024
Q4 | $5K | Sell |
9,526
-44,111
| -82% | -$30.7K | ﹤0.01% | 7689 |
|
|
2024
Q3 | $94K | Sell |
53,637
-11,404
| -18% | -$15.9K | ﹤0.01% | 5303 |
|
|
2024
Q2 | $76K | Sell |
65,041
-27,230
| -30% | -$68.1K | ﹤0.01% | 5667 |
|
|
2024
Q1 | $834K | Buy |
+92,271
| New | +$897K | ﹤0.01% | 3309 |
|
|
2023
Q4 | – | Sell |
-7,895
| Closed | -$59.2K | – | 10132 |
|
|
2023
Q3 | $63K | Sell |
7,895
-83,840
| -91% | -$697K | ﹤0.01% | 5587 |
|
|
2023
Q2 | $996K | Sell |
91,735
-19,182
| -17% | -$164K | ﹤0.01% | 2604 |
|
|
2023
Q1 | $765K | Buy |
110,917
+26,912
| +32% | +$169K | ﹤0.01% | 2845 |
|
|
2022
Q4 | $334K | Buy |
84,005
+50,663
| +152% | +$249K | ﹤0.01% | 3616 |
|
|
2022
Q3 | $221K | Buy |
33,342
+32,368
| +3,323% | +$199K | ﹤0.01% | 4481 |
|
|
2022
Q2 | $4K | Buy |
+974
| New | +$5.92K | ﹤0.01% | 9065 |
|
|
2021
Q4 | – | Sell |
-8,193
| Closed | -$94.6K | – | 11693 |
|
|
2021
Q3 | $153K | Sell |
8,193
-200
| -2% | -$2.75K | ﹤0.01% | 6016 |
|
|
2021
Q2 | $150K | Sell |
8,393
-164
| -2% | -$2.64K | ﹤0.01% | 6136 |
|
|
2021
Q1 | $132K | Sell |
8,557
-1,312
| -13% | -$19K | ﹤0.01% | 5361 |
|
|
2020
Q4 | $0 | Buy |
9,869
+2,475
| +33% | +$34.5K | ﹤0.01% | 9258 |
|
|
2020
Q3 | $95K | Buy |
7,394
+2,719
| +58% | +$23.5K | ﹤0.01% | 4958 |
|
|
2020
Q2 | $47K | Sell |
4,675
-786
| -14% | -$7.23K | ﹤0.01% | 5558 |
|
|
2020
Q1 | $44K | Buy |
5,461
+2,552
| +88% | +$22.1K | ﹤0.01% | 5275 |
|
|
2019
Q4 | $25K | Buy |
2,909
+2,140
| +278% | +$12K | ﹤0.01% | 5797 |
|
|
2019
Q3 | $4K | Sell |
769
-16,187
| -95% | -$131K | ﹤0.01% | 6734 |
|
|
2019
Q2 | $281K | Sell |
16,956
-46,594
| -73% | -$809K | ﹤0.01% | 3134 |
|
|
2019
Q1 | $1.06M | Buy |
63,550
+44,084
| +226% | +$635K | ﹤0.01% | 1951 |
|
|
2018
Q4 | $223K | Buy |
19,466
+13,155
| +208% | +$266K | ﹤0.01% | 3048 |
|
|
2018
Q3 | $252K | Buy |
+6,311
| New | +$180K | ﹤0.01% | 3386 |
|
|
2018
Q2 | – | Sell |
-12,565
| Closed | -$279K | – | 8011 |
|
|
2018
Q1 | $191K | Buy |
12,565
+12,061
| +2,393% | +$287K | 0.01% | 1274 |
|
|
2017
Q4 | $16K | Buy |
504
+262
| +108% | +$7.06K | ﹤0.01% | 3527 |
|
|
2017
Q3 | $5K | Buy |
+242
| New | +$2.71K | ﹤0.01% | 4450 |
|
Simplex Trading's MRNS Position: Q1 2025 in Review
Simplex Trading sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 9,526 shares — an estimated $5K sold.
Simplex Trading first reported a position in MRNS in Q3 2017 and held it in 26 quarters. The position peaked at $1.06M in Q1 2019. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.
- Simplex Trading reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
- Simplex Trading sold 9,526 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $5K.
- Simplex Trading first reported a position in Marinus Pharmaceuticals, Inc in Q3 2017 and held it in 26 quarters.
- Simplex Trading's Marinus Pharmaceuticals, Inc position peaked at $1.06M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.
Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.